These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24913562)

  • 1. Combination therapy with thioridazine and dicloxacillin combats meticillin-resistant Staphylococcus aureus infection in Caenorhabditis elegans.
    Poulsen MØ; Schøler L; Nielsen A; Skov MN; Kolmos HJ; Kallipolitis BH; Olsen A; Klitgaard JK
    J Med Microbiol; 2014 Sep; 63(Pt 9):1174-1180. PubMed ID: 24913562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of thioridazine and dicloxacillin as a possible treatment strategy of staphylococci.
    Rasmussen KS; Poulsen MØ; Jacobsen K; Skov MN; Kolmos HJ; Kallipolitis BH; Klitgaard JK
    New Microbiol; 2017 Apr; 40(2):146-147. PubMed ID: 28255602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model.
    Stenger M; Hendel K; Bollen P; Licht PB; Kolmos HJ; Klitgaard JK
    PLoS One; 2015; 10(8):e0135571. PubMed ID: 26267376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Drug Resistance of
    Luan W; Liu X; Wang X; An Y; Wang Y; Wang C; Shen K; Xu H; Li S; Liu M; Yu LU
    Pol J Microbiol; 2019 Dec; 68(4):477-491. PubMed ID: 31880892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity.
    Stenger M; Behr-Rasmussen C; Klein K; Grønnemose RB; Andersen TE; Klitgaard JK; Kolmos HJ; Lindholt JS
    PLoS One; 2017; 12(3):e0173362. PubMed ID: 28278183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of thioridazine resistance in Staphylococcus aureus.
    Wassmann CS; Lund LC; Thorsing M; Lauritzen SP; Kolmos HJ; Kallipolitis BH; Klitgaard JK
    PLoS One; 2018; 13(8):e0201767. PubMed ID: 30089175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model.
    Kong C; Yehye WA; Abd Rahman N; Tan MW; Nathan S
    BMC Complement Altern Med; 2014 Jan; 14():4. PubMed ID: 24393217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioridazine potentiates the effect of a beta-lactam antibiotic against Staphylococcus aureus independently of mecA expression.
    Poulsen MØ; Jacobsen K; Thorsing M; Kristensen NR; Clasen J; Lillebæk EM; Skov MN; Kallipolitis BH; Kolmos HJ; Klitgaard JK
    Res Microbiol; 2013; 164(2):181-8. PubMed ID: 23089256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection.
    Stenger M; Klein K; Grønnemose RB; Klitgaard JK; Kolmos HJ; Lindholt JS; Alm M; Thomsen P; Andersen TE
    J Control Release; 2016 Nov; 241():125-134. PubMed ID: 27663229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA.
    Chang HC; Huang YT; Chen CS; Chen YW; Huang YT; Su JC; Teng LJ; Shiau CW; Chiu HC
    J Antimicrob Chemother; 2016 Feb; 71(2):449-59. PubMed ID: 26553845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP; Gemmell CG; Coote PJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study.
    Martins M; Bleiss W; Marko A; Ordway D; Viveiros M; Leandro C; Pacheco T; Molnar J; Kristiansen JE; Amaral L
    In Vivo; 2004; 18(6):787-94. PubMed ID: 15646821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRSA decolonization of cotton rat nares by a combination treatment comprising lysostaphin and the antimicrobial peptide ranalexin.
    Desbois AP; Sattar A; Graham S; Warn PA; Coote PJ
    J Antimicrob Chemother; 2013 Nov; 68(11):2569-75. PubMed ID: 23800902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening.
    Kim SM; Escorbar I; Lee K; Fuchs BB; Mylonakis E; Kim W
    J Microbiol; 2020 Jun; 58(6):431-444. PubMed ID: 32462486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
    Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
    J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring anti-MRSA activity of chitosan-coated liposomal dicloxacillin.
    Alshamsan A; Aleanizy FS; Badran M; Alqahtani FY; Alfassam H; Almalik A; Alosaimy S
    J Microbiol Methods; 2019 Jan; 156():23-28. PubMed ID: 30465793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.
    Baldoni D; Furustrand Tafin U; Aeppli S; Angevaare E; Oliva A; Haschke M; Zimmerli W; Trampuz A
    Int J Antimicrob Agents; 2013 Sep; 42(3):220-5. PubMed ID: 23880168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
    Lowrence RC; Raman T; Makala HV; Ulaganathan V; Subramaniapillai SG; Kuppuswamy AA; Mani A; Chittoor Neelakantan S; Nagarajan S
    Appl Microbiol Biotechnol; 2016 Nov; 100(21):9265-9281. PubMed ID: 27531512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caenorhabditis elegans as a host model for community-associated methicillin-resistant Staphylococcus aureus.
    Wu K; Conly J; McClure JA; Elsayed S; Louie T; Zhang K
    Clin Microbiol Infect; 2010 Mar; 16(3):245-54. PubMed ID: 19456837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.